This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Polk, D. B. Articles by Kerner, J. A. Search for Related Content PubMed PubMed Citation Articles by Polk, D. B. Articles by Kerner, J. A., JR Social Bookmarking                         What's this?

Improved Growth and Disease Activity After Intermittent Administration of a Defined Formula Diet in Children With Crohn's Disease

Department of Pediatrics, Stanford University School of Medicine, Stanford, California

Jo Ann T. Hattner, MPH, RD

Department of Pediatrics, Stanford University School of Medicine, Stanford, California

John A. Kerner, JR, MD

Department of Pediatrics, Stanford University School of Medicine, Stanford, California

Growth failure is the most common extraintestinal manifestation of Crohn's disease in childhood, occurring in up to 50% to 88% of affected patients. Previous studies have shown malnutrition to be the most likely cause of the decrease in height and weight velocities in these children. The purpose of this study was to determine the effect of an intermittent defined formula diet on growth and disease activity in children with Crohn's disease and growth failure. Six Tanner stage I-II patients, mean age 13.6 years with height less than the 5th percentile or height velocity less than the 3rd percentile were enrolled in a 1-year prospective study. An isotonic, hydrolyzed whey, medium-chain triglyceride formula was given by nocturnal nasogastric infusion at a caloric equivalent of 50th percentile for age, as the exclusive nutrient source 1 out of 4 months during a 1-year period. A 2-week exclusion diet and a 2-week low-residue diet followed the defined formula diet before resuming the regular diet for 2 months. Patients served as their individual control based on observations of at least 1 year before the study. Height and weight velocity significantly increased. Prednisone intake significantly decreased, and significant improvement was seen in disease activity, albumin, and somatomedin C. The results indicate that an intermittent defined formula diet can improve growth failure and significantly decrease disease activity in children with Crohn's disease. (Journal of Parenteral and Enteral Nutrition 16:499-504, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 6, 499-504 (1992)
DOI: 10.1177/0148607192016006499


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. M. Beattie Enteral Nutrition as Primary Therapy in Childhood Crohn's Disease: Control of Intestinal Inflammation and Anabolic Response JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S151 - S159. [Abstract] [Full Text] [PDF]

				K. N. Jeejeebhoy Clinical nutrition: 6. Management of nutritional problems of patients with Crohn's disease Can. Med. Assoc. J., April 1, 2002; 166(7): 913 - 918. [Full Text] [PDF]

				American Society for Parenteral and Enteral Nutrit Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients JPEN J Parenter Enteral Nutr, January 1, 2002; 26(1_suppl): 1SA - 138SA. [PDF]

				S. Klein, J. Kinney, K. Jeejeebhoy, D. Alpers, M. Hellerstein, M. Murray, and P. Twomey Nutrition Support in Clinical Practice: Review of Published Data and Recommendations for Future Research Directions: Summary of a Conference Sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition JPEN J Parenter Enteral Nutr, May 1, 1997; 21(3): 133 - 156. [Abstract] [PDF]

				M. Cosgrove and H. R Jenkins Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease Arch. Dis. Child., February 1, 1997; 76(2): 141 - 143. [Abstract] [Full Text]

				V. Khoshoo, R. Reifen, M. G. Neuman, A. Griffiths, and P. B. Pencharz Effect of Low- and High-Fat, Peptide-Based Diets on Body Composition and Disease Activity in Adolescents With Active Crohn's Disease JPEN J Parenter Enteral Nutr, November 1, 1996; 20(6): 401 - 405. [Abstract] [PDF]